Overview

  • Product nameHerbimycin A
  • Description
    Cell-permeable Src tyrosine kinase inhibitor
  • Biological descriptionCell-permeable Src tyrosine kinase inhibitor and ansamycin antibiotic. Binds to the SH domain and inhibits p60v-src and p210BCR-ABL activity. Specific IKKβ and angiogenesis inhibitor. Anti-bacterial, anti-inflammatory and antitumor effects. Active in vitro and in vivo.
  • Purity> 98%

Properties

    References for Herbimycin A (ab142310)

    This product has been referenced in:
    • Ogino S  et al. Herbimycin A abrogates nuclear factor-kappaB activation by interacting preferentially with the IkappaB kinase beta subunit. Mol Pharmacol 65:1344-51 (2004). Read more (PubMed: 15155828) »
    • Fukazawa H  et al. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism. FEBS Lett 340:155-8 (1994). Read more (PubMed: 8131836) »
    • Uehara Y  et al. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem Biophys Res Commun 163:803-9 (1989). Read more (PubMed: 2783121) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab142310.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"